Pizotifen (BC-105): a Review of Its Pharmacological Properties and Its Therapeutic Efficacy in Vascular Headaches

Overview

Journal Drugs

Specialty Pharmacology

Date 1972 Jan 1

PMID 4403890

Citations 27

Authors

T M Speight

G S Avery

Affiliations

Soon will be listed here.

Citing Articles

Pizotifen inhibits the proliferation and invasion of gastric cancer cells.

Jiang Y, Wang W, Wu X, Shi J Exp Ther Med. 2020; 19(2):817-824.

PMID: 32010241 PMC: 6966152. DOI: 10.3892/etm.2019.8308.

Cluster headache: present and future therapy.

Leone M, Giustiniani A, Proietti Cecchini A Neurol Sci. 2017; 38(Suppl 1):45-50.

PMID: 28527055 DOI: 10.1007/s10072-017-2924-7.

Evidence-based treatments for cluster headache.

Gooriah R, Buture A, Ahmed F Ther Clin Risk Manag. 2015; 11:1687-96.

PMID: 26635477 PMC: 4646474. DOI: 10.2147/TCRM.S94193.

Cluster headache.

Matharu M BMJ Clin Evid. 2011; 2010.

PMID: 21718584 PMC: 2907610.

Serotonergic agents in the management of cluster headache.

Lambru G, Matharu M Curr Pain Headache Rep. 2011; 15(2):108-17.

PMID: 21271306 DOI: 10.1007/s11916-011-0176-4.

References

CHAKRABARTY A, Pillai R, Anand B, Singh B . Effect of cyproheptadine on the electrical activity of the hypothalamic feeding centres. Brain Res. 1967; 6(3):561-9. DOI: 10.1016/0006-8993(67)90066-2. View

Wilson I, Prange Jr A, McCLANE T, Rabon A, LIPTON M . Thyroid-hormone enhancement of imipramine in nonretarded depressions. N Engl J Med. 1970; 282(19):1063-7. DOI: 10.1056/NEJM197005072821903. View

Mertz D, Stelzer M . [Mechanism of the appetite and body weight increasing effect of cyproheptadine. I. Clinical experience and hormone iodine studies]. Klin Wochenschr. 1969; 47(22):1189-94. DOI: 10.1007/BF01484880. View

Kaley G, Weiner R . Prostaglandin E-1: a potential mediator of the inflammatory response. Ann N Y Acad Sci. 1971; 180:338-50. DOI: 10.1111/j.1749-6632.1971.tb53203.x. View

Luyckx A, Lefebvre P . [Effects of a serotonin antagonist (BC 105 Sandoz) on carbohydrate metabolism]. Rev Med Liege. 1970; 25(13):414-21. View

BAROLIN G . [Long-term therapy of persistent migraine with BC-105]. Z Allgemeinmed. 1970; 46(22):1130-3. View

Lance J, Anthony M . A comparative trial of serotonin antagonists in the management of migraine. Proc Aust Assoc Neurol. 1970; 7:31-5. View

SICUTERI F, Del Bianco P, Ansemli B . Migraine as a cyclic disease with latent and overt components--effects with an antaminic drug. Headache. 1970; 10(2):53-62. DOI: 10.1111/j.1526-4610.1970.hed1002053.x. View

Hughes R, Foster J . BC 105 in the prophylaxis of migraine. Curr Ther Res Clin Exp. 1971; 13(1):63-8. View

10.

KRUMHOLZ W, Yaryura-Tobias J, White L . The action of BC-105 in chronic schizophrenics with depression. Curr Ther Res Clin Exp. 1968; 10(7):342-4. View

11.

CURRAN D, Hinterberger H, Lance J . Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965; 88(5):997-1010. DOI: 10.1093/brain/88.5.997. View

12.

Ekbom K . Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurol Scand. 1969; 45(5):601-10. DOI: 10.1111/j.1600-0404.1969.tb01270.x. View

13.

SICUTERI F, Franchi G, Del Bianco P . An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences. Int Arch Allergy Appl Immunol. 1967; 31(1):78-93. DOI: 10.1159/000229856. View

14.

Sjaastad O, Stensrud P . Appraisal of BC-105 in migraine prophylaxis. Acta Neurol Scand. 1969; 45(5):594-600. DOI: 10.1111/j.1600-0404.1969.tb01269.x. View

15.

Ekbom K . Nitrolglycerin as a provocative agent in cluster headache. Arch Neurol. 1968; 19(5):487-93. DOI: 10.1001/archneur.1968.00480050057005. View

16.

Lance J, Anthony M, Somerville B . Comparative trial of serotonin antagonists in the management of migraine. Br Med J. 1970; 2(5705):327-30. PMC: 1700164. DOI: 10.1136/bmj.2.5705.327. View

17.

Arthur G, Hornabrook R . The treatment of migraine with BC 105 (pizotifen): a double blind trial. N Z Med J. 1971; 73(464):5-9. View

18.

SICUTERI F . MAST CELLS AND THEIR ACTIVE SUBSTANCES: THEIR ROLE IN THE PATHOGENESIS OF MIGRAINE. Headache. 1963; 3:86-92. DOI: 10.1111/j.1526-4610.1963.hed0303086.x. View

19.

Loong S, Lance J, Rawle K . The control of flushing and diarrhoea in carcinoid syndrome by an antiserotonin agent, BC105. Med J Aust. 1968; 2(19):845-8. View

20.

Mertz D, Klopfer M . [Mechanism of the appetite and body weight increasing effect of cyproheptadine. 3. Changes in lipid metabolism]. Klin Wochenschr. 1969; 47(22):1197-200. DOI: 10.1007/BF01484882. View